Search
for

    Did you mean Alpha-blockers?
    Glossary Alpha-blockers

    medications that relax blood vessels by blocking norepinephrine

    Alpha-blockers, also known as alpha-adrenergic antagonists, are medications that relax certain muscles and help small blood vessels remain open. They work by blocking the action of norepinephrine, a hormone that tightens the muscles in the walls of smaller arteries and veins. This can improve blood flow and lower blood pressure, making them useful in treating conditions like hypertension and benign prostatic hyperplasia (BPH).

    Related Terms

    Sort by

    Research 30 of 1000+

    1. Evaluating the safety profile of α-1 blockers, 5α-reductase inhibitors, and PDE5I for BPH: a disproportionality analysis of real-world adverse events based on FDA adverse event reporting system (FAERS) Figshare · 2026
    2. Evaluating the safety profile of α-1 blockers, 5α-reductase inhibitors, and PDE5I for BPH: a disproportionality analysis of real-world adverse events based on FDA adverse event reporting system (FAERS) Figshare · 2026
    3. Evaluating the safety profile of α-1 blockers, 5α-reductase inhibitors, and PDE5I for BPH: a disproportionality analysis of real-world adverse events based on FDA adverse event reporting system (FAERS) The Aging Male · 2026
    4. A Comparison of Varying alpha-Blockers and Other Pharmacotherapy Options for Lower Urinary Tract Symptoms. PubMed · 2005 · 52 citations
    5. Review: Adding α<sub>1</sub>-blockers to 5α-reductase inhibitors improves lower urinary tract symptoms in men Annals of Internal Medicine · 2014
    6. Referee report. For: Recent advances in treatment for Benign Prostatic Hyperplasia [version 1; referees: 2 approved] Faculty of 1000 Research Ltd · 2015
    7. Efficacy and Side Effects of Drugs Commonly Used for the Treatment of Lower Urinary Tract Symptoms Associated With Benign Prostatic Hyperplasia Frontiers in Pharmacology · 2020 · 35 citations
    8. Cognitive and mood side effects of lower urinary tract medication Expert Opinion on Drug Safety · 2019 · 20 citations
    9. Trends in the Development of New Drugs for Treatment of Benign Prostatic Hyperplasia Current Medicinal Chemistry · 2006 · 14 citations
    10. Medikamentöse Therapie der BPH Ist eine Kombinationstherapie mit 5α-Reduktasehemmern und α-Rezeptorenblockern sinnvoll? Der Urologe · 2002 · 4 citations
    11. Medikamentöse Therapie des benignen Prostatasyndroms (BPS) Aktuelle Urologie · 2006
    12. Immunolocalization of 5α-Reductase Isozymes in Acne Lesions and Normal Skin Archives of dermatology · 2000 · 45 citations
    13. 5-Alpha-Reductase Inhibitors and Combination Therapy Urologic Clinics of North America · 2016 · 15 citations
    14. Sexual Dysfunctions Related to Drugs Used in the Management of Lower Urinary Tract Symptoms Due to Benign Prostatic Hyperplasia: A Narrative Review on α-Blockers and 5-Alpha Reductase Inhibitors Uro · 2021 · 6 citations
    15. THE ROLE Of 5αR AND α1AR INHIBITORS IN MANAGEMENT OF BPH 2019
    16. Analysis of Data From Breast Diseases Treated With 5-Alpha Reductase Inhibitors for Benign Prostatic Hyperplasia Clinical Breast Cancer · 2019 · 1 citations
    17. MP09-16 5-ALPHA REDUCTASE INHIBITORS FOR MALE LOWER URINARY TRACT SYMPTOMS: A COCHRANE SYSTEMATIC REVIEW AND META-ANALYSIS 2017
    18. Hidradenitis Suppurativa/Acne Inversa/Dissecting Terminal Hair Folliculitis Springer eBooks · 2019 · 1 citations
    19. Skin manifestations associated with COVID-19 Anais Brasileiros de Dermatologia · 2021 · 18 citations
    20. Comparison of clinical trials with finasteride and dutasteride. PubMed · 2004 · 20 citations
    21. Immunological Properties of Atopic Dermatitis-Associated Alopecia Areata International Journal of Molecular Sciences · 2021 · 57 citations
    22. Serenoa Repens (Saw Palmetto) for Lower Urinary Tract Symptoms (LUTS): The Evidence for Efficacy and Safety of Lipidosterolic Extracts. Part III Uro · 2021 · 3 citations
    23. Treatment response to conventional and novel therapies in chronic prostatitis Current Prostate Reports · 2003
    24. Bladder Cancer Survival of Men Receiving 5α-Reductase Inhibitors The Journal of Urology · 2018 · 20 citations
    25. Intraoperative floppy iris syndrome Current Opinion in Ophthalmology · 2008 · 41 citations
    26. Bladder cancer survival in men using 5-alpha-reductase inhibitors European Urology Supplements · 2018 · 3 citations
    27. Medikamentöse Therapie des benignen Prostatasyndroms mit α1-Rezeptorblockern Grundlagen und klinische Ergebnisse Der Urologe · 2002 · 22 citations
    28. Risk factors for intraoperative floppy iris syndrome: One year prospective study Acta Ophthalmologica · 2013
    29. Floppy Iris Syndrome Essentials in ophthalmology · 2022
    30. Current treatment of BPH Biomedicine & pharmacotherapy · 1995 · 11 citations